GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (FRA:4OR) » Definitions » Future 3-5Y EPS without NRI Growth Rate

VivoSim Labs (FRA:4OR) Future 3-5Y EPS without NRI Growth Rate : 60.59 (As of May. 21, 2025)


View and export this data going back to 2013. Start your Free Trial

What is VivoSim Labs Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate is 60.59.


Competitive Comparison of VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

VivoSim Labs  (FRA:4OR) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


VivoSim Labs Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of VivoSim Labs's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


VivoSim Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VivoSim Labs Inc (FRA:4OR) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
Address
11555 Sorrento Valley road, Suite 100, San Diego, CA, USA, 92121
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

VivoSim Labs Headlines

No Headlines